Reference
Gong Z, et al. Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood Cancer Journal 14: Jan 2024. Available from: URL: https://dx.doi.org/10.1038/s41408-024-01023-9
Rights and permissions
About this article
Cite this article
Teclistamab. Reactions Weekly 2008, 327 (2024). https://doi.org/10.1007/s40278-024-59221-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-59221-6